Company intelligence / Profile preview

Reshape Biotech

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Reshape Biotech has developed a commercialized robotic and AI-powered lab automation platform that digitizes microbiology experiments. Their systems are deployed in leading biotech, agriculture, food ingredient companies, and academic labs to automate plate-based assays with high-throughput imaging and real-time AI analytics. Customers report significant increases in throughput, data quality, reproducibility, and efficiency.

Modalities: Device (lab automation robots)Software platform (AI-driven analysis)
Industry: Drug Discovery Services

Partnerships

Syngenta (agricultural trait screening automation)Chr. Hansen (animal nutrition product development acceleration)DTU Biosustain at Technical University of DenmarkImperial College London metabolic engineering group

Beyond the preview

Go deeper on Reshape Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reshape Biotech.

Explore the full profile